Remove 2030 Remove Dosage Remove Packaging
article thumbnail

Morepen Laboratories expands its domestic portfolio

Express Pharma

These launches form part of Morepens broader strategy to enhance its finished dosages segment while leveraging its internal research and development (R&D) capabilities. The product is offered in a 4×14 patient-compliant pack with day/night markers and matte foil packaging. The company notes its 98.23

article thumbnail

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Express Pharma

As environmental concerns continue to intensify, the pressure on the pharmaceutical industry to reduce its overall environmental impact, particularly in final dosage forms, is growing proportionately. We have committed to reduce our scope 1 and 2 GHG emissions by 42 per cent (absolute) by the end of 2030 (from a 2021 basis).

Dosage 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

17th edition of CPHI & PMEC India inaugurated at India Expo Centre, Noida

Express Pharma

With the Indian pharma market projected to grow to $ 130 billion by 2030 and $ 450 billion by 2047, the event highlighted the industry’s vital role in shaping global healthcare. Projections indicate exports will soar to $130 billion by 2030 and $450 billion by 2047. trillion.

Packaging 105
article thumbnail

Advancements in Biopharma Spur Innovation

PharmaTech

The global biopharma industry is expected to increase at a compound annual growth rate of 8.97% from 2025 to 2030; this growth is suspected to result from a demand for targeted therapies, new alliances, and increased innovation (1).

Dosage 52
article thumbnail

Elkedonia Raises €11.25M Seed Round to Advance Neuroplastogen Therapy for Depression

PharmaTech

The financing round was co-led by Kurma Partners , WE Life Sciences , and the French Tech Seed Fund managed by Bpifrance , on behalf of the French government, under the France 2030 initiative. Additional participants included Argobio , Angelini Ventures , CARMA Fund , Capital Grand Est , and Sambrinvest.

Dosage 52